Association of the IgG N-glycome with the course of kidney function in type 2 diabetes

BMJ Open Diabetes Res Care. 2020 Apr;8(1):e001026. doi: 10.1136/bmjdrc-2019-001026.

Abstract

Introduction: Inflammatory processes are thought to be involved in kidney function decline in individuals with type 2 diabetes. Glycosylation of immunoglobulin G (IgG) is an important post-translation process affecting the inflammatory potential of IgG. We investigated the prospective relationship between IgG N-glycosylation patterns and kidney function in type 2 diabetes.

Research design and methods: In the DiaGene study, an all-lines-of-care case-control study (n=1886) with mean prospective follow-up of 7.0 years, the association between 58 IgG N-glycan profiles and estimated glomerular filtration rate (eGFR) and albumin-to-creatinine ratio (ACR) per year and during total follow-up was analyzed. Models were adjusted for clinical variables and multiple comparisons.

Results: Eleven traits were significantly associated with eGFR change per year. Bisecting GlcNAc in fucosylated and fucosylated disialylated structures and monosialylation of fucosylated digalactosylated structures were associated with a faster decrease of eGFR. Fucosylation of neutral and monogalactosylated structures was associated with less eGFR decline per year. No significant associations between IgG glycans and ACR were found.

Conclusions: In type 2 diabetes, we found IgG N-glycosylation patterns associated with a faster decline of kidney function, reflecting a pro-inflammatory state of IgG. eGFR, but not ACR, was associated with IgG glycans, which suggests these associations may represent renal macroangiopathy rather than microvascular disease.

Keywords: IgG N-glycans; N-glycosylation; diabetes type 2; kidney function; nephropathy.

MeSH terms

  • Case-Control Studies
  • Diabetes Mellitus, Type 2*
  • Humans
  • Immunoglobulin G*
  • Kidney
  • Prospective Studies

Substances

  • Immunoglobulin G